. 2016 Apr 7;2016:6830713. doi: 10.1155/2016/6830713

Table 3.

Odds ratio (OR) and 95% confidence interval (CI) of detection of advanced neoplasm using colonoscopy as a gold standard by gender, age group, and fecal immunochemical test (FIT) status in the Jiashan mass colorectal cancer screening program in China, 2007–2009.

Gender	Age	FIT	Colonoscopy participant	Advanced neoplasm	OR1 (95% CI)	OR2 (95% CI)	OR3 (95% CI )
Gender	Age	FIT	Colonoscopy participant	n (%)	OR1 (95% CI)	OR2 (95% CI)	OR3 (95% CI )
Men	<55	FIT1	182	23 (12.6)	1.0		1.0
		FIT2	162	15 (9.3)	0.71 (0.35–1.40)	1.0	1.0
		Both	54	11 (20.4)	1.77 (0.80–3.91)	2.51 (1.07–5.86)	1.0
		Either	294	27 (9.2)	0.70 (0.39–1.26)	0.99 (0.51–1.92)	1.0

Men	≥55	FIT1	245	42 (17.1)	1.0		1.43 (0.83–2.48)^a
		FIT2	196	28 (14.3)	0.81 (0.48–1.36)	1.0	1.63 (0.84–3.18)^b
		Both	73	20 (27.4)	1.82 (0.99–3.37)	2.26 (1.18–4.34)	1.48 (0.64–3.41)^c
		Either	368	50 (13.6)	0.76 (0.49–1.19)	0.94 (0.57–1.55)	1.56 (0.95–2.55)^d

Women	<55	FIT1	257	11 (4.3)	1.0		1.0
		FIT2	198	7 (3.5)	0.82 (0.31–2.15)	1.0	1.0
		Both	57	4 (7.0)	1.69 (0.52–5.51)	2.06 (0.59–7.30)	1.0
		Either	398	14 (3.5)	0.82 (0.36–1.83)	1.0 (0.40–2.51)	1.0

Women	≥55	FIT1	237	27 (11.4)	1.0		2.88 (1.39–5.94)^e
		FIT2	198	22 (11.1)	0.97 (0.54–1.77)	1.0	3.41 (1.42–8.18)^f
		Both	66	13 (19.7)	1.91 (0.92–3.95)	1.96 (0.93–4.16)	3.25 (1.00–10.61)^g
		Either	369	36 (9.8)	0.84 (0.50–1.43)	0.87 (0.49–1.52)	2.97 (1.57–5.59)^h

Men	All	FIT1	432	65 (15.0)	1.0		1.0
		FIT2	358	43 (12.0)	0.77 (0.51–1.17)	1.0	1.0
		Both	127	31 (24.4)	1.82 (1.13–2.96)	2.34 (1.41–3.96)	1.0
		Either	663	77 (11.6)	0.74 (0.52–1.06)	0.96 (0.65–1.43)	1.0

Women	All	FIT1	494	38 (7.7)	1.0		0.47 (0.31–0.72)^a
		FIT2	396	29 (7.3)	0.95 (0.57–1.57)	1.0	0.58 (0.35–0.95)^b
		Both	123	17 (11.4)	1.93 (1.05–3.54)	2.03 (1.07–3.84)	0.50 (0.26–0.95)^c
		Either	767	56 (7.3)	0.95 (0.62–1.45)	1.00 (0.63–1.59)	0.60 (0.42–0.86)^d

Both	All	FIT1	926	103 (11.1)	1.0		—
		FIT2	754	72 (9.5)	0.84 (0.61–1.16)	1.0	—
		Both	250	48 (19.2)	1.90 (1.30–2.76)	2.25 (1.51–3.35)	—
		Either	1,430	127 (8.9)	0.78 (0.59–1.02)	0.92 (0.68–1.25)	—

FIT1, the first FIT; FIT2, the second FIT; OR1 using FIT1 as reference and OR2 using FIT2 as reference; OR3^a using men with age <55 who completed FIT1 as reference, OR3^b using men with age <55 who completed FIT2 as reference, OR3^c using men with age <55 who completed both FIT1 and FIT2 as reference, OR3^d using men with age <55 who completed either FIT1 or FIT2 as reference, OR3^e using women with age <55 who completed FIT1 as reference, OR3^f using women with age <55 who completed FIT2 as reference, OR3^g using women with age <55 who completed both FIT1 and FIT2 as reference, and OR3^h using women with age <55 who completed either FIT1 or FIT2 as reference.